Study results released on Monday revealed that a personalized mRNA vaccine manufactured by Moderna and Merck has shown ...
2don MSN
‘King Keytruda’s reign continues.’ Investors aren’t wowed by a promising new lung cancer drug
The highly anticipated study found that ivonescimab reduced the risk of death by 34% compared with another drug ...
The highly anticipated study found that ivonescimab reduced the risk of death by 34% compared with another drug Summit Therapeutics and Akeso shared more data for their experimental lung-cancer drug ...
A number of companies presented new data on their cancer vaccine candidates at ASCO 2026.
The combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful ...
The combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful ...
Since 2015, NHS patients have received the world's best-selling drug through a drip – or intravenous infusion – which can take more than an hour to administer in hospital. NHS England says the new ...
SurvivorNet on MSN
A new type of immunotherapy drug showed striking results in hard-to-treat lung cancer, but more data is needed for US patients
A large clinical trial in China (HARMONi-6) found that a new immunotherapy drug, ivonescimab, may help patients with advanced ...
The Department of Health (DoH) said it is "aware" of the jab and is "exploring" how it can be made available to patients in Northern Ireland "as soon as possible".
Merck & Co.’s extensive clinical development scheme for its TROP2 antibody-drug conjugate (ADC) sac-TMT already ...
The combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful in cutting the risk of skin cancer recurrence and death by 49 percent, a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results